Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges

References

• KesslerRCBerglundPDemlerOThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA20032893095310512813115
   PubMed Web of Science ®Google Scholar
• BurtVKEpidemiology of depression throughout the female life cycleJ Clin Psychiatry20026391511995779
   PubMed Web of Science ®Google Scholar
• BurkeKCBurkeJDRaeDSRegirerDAComparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populationsArch Gen Psychiatry1991487897951929768
   PubMed Web of Science ®Google Scholar
• GavinNIGaynesBNLohrKNMeltzer-BrodySGartlehnerGSwinsonTPerinatal depression: a systematic review of prevalence and incidenceObstet Gynecol20051061071108316260528
   PubMed Web of Science ®Google Scholar
• MarcusSMFlynnHABlowFCBarryKLDepressive symptoms among pregnant women screened in obstetrics settingsJ Womens Health (Larchmt)20031237338012804344
   PubMed Web of Science ®Google Scholar
• OberlanderTFWarburtonWMisriSAghajanianJHertzmanCNeonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health dataArch Gen Psychiatry20066389890616894066
   PubMed Web of Science ®Google Scholar
• BennettHAEinarsonAKorenGEinarsonTRPrevalence of depression during pregnancy: systematic reviewObstet Gynecol200410369870915051562
   PubMed Web of Science ®Google Scholar
• NuttDJDavidsonJRGelenbergAJInternational consensus statement on major depressive disorderJ Clin Psychiatry201071Suppl E1e0820371035
   PubMedGoogle Scholar
• CooperWOWillyMEPontSJRayWAIncreasing use of antidepressants in pregnancyAm J Obstet Gynecol200719654454517547888
   PubMed Web of Science ®Google Scholar
• AndradeSERaebelMABrownJUse of antidepressant medications during pregnancy: a multisite studyAm J Obstet Gynecol200819819419517905176
   PubMed Web of Science ®Google Scholar
• RamosEOraichiDReyEBlaisLBérardAPrevalence and predictors of antidepressant use in a cohort of pregnant womenBJOG20071141055106417565615
   PubMed Web of Science ®Google Scholar
• VerversTKaasenbroodHVisserGSchobbenFde Jong-van den BergLEgbertsTPrevalence and patterns of antidepressant drug use during pregnancyEur J Clin Pharmacol20066286387016896784
   PubMed Web of Science ®Google Scholar
• BakkerMKKöllingPvan den BergPBde WalleHEde Jong van den BergLTIncrease in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from The NetherlandsBr J Clin Pharmacol20086560060617953715
   PubMed Web of Science ®Google Scholar
• KuehnBMNo easy answers for physicians caring for pregnant women with depressionJAMA200930224132414242019996392
   PubMed Web of Science ®Google Scholar
• WisnerKLAppelbaumPSUhlKGoldkindSFPharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential dataClin Pharmacol Ther20098636236519763116
   PubMed Web of Science ®Google Scholar
• YonkersKAWisnerKLStewartDEThe management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and GynecologistsObstet Gynecol200911470371319701065
   PubMed Web of Science ®Google Scholar
• ZuckermanBAmaroHBauchnerHCabralHDepressive symptoms during pregnancy: relationship to poor health behaviorsAm J Obstet Gynecol1989160110711112729387
   PubMed Web of Science ®Google Scholar
• PerkinMRBlandJMPeacockJLAndersonHRThe effect of anxiety and depression during pregnancy on obstetric complicationsBr J Obstet Gynaecol19931006296348369244
   PubMedGoogle Scholar
• PritchardCWDepression and smoking in pregnancy in ScotlandJ Epidemiol Community Health1994483773827964337
   PubMed Web of Science ®Google Scholar
• IkardFFTomkinsSThe experience of affect as a determinant of smoking behavior: a series of validity studiesJ Abnorm Psychol1973811721814697798
   PubMed Web of Science ®Google Scholar
• OrrSTBlazerDGJamesSAReiterJPDepressive symptoms and indicators of maternal health status during pregnancyJ Womens Health (Larchmt)20071653554217521257
   PubMed Web of Science ®Google Scholar
• StoweZNHostetterALNewportDJThe onset of postpartum depression: implications for clinical screening in obstetrical and primary careAm J Obstet Gynecol200519252252615695997
   PubMed Web of Science ®Google Scholar
• NulmanIKorenGRovetJNeurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depressionAm J Psychiatry20121691165117423128923
   PubMed Web of Science ®Google Scholar
• LindahlVPearsonJLColpeLPrevalence of suicidality during pregnancy and the postpartumArch Womens Ment Health20058778715883651
   PubMed Web of Science ®Google Scholar
• PearlsteinTPerinatal depression: treatment options and dilemmasJ Psychiatry Neurosci20083330231818592032
   PubMed Web of Science ®Google Scholar
• VintzileosAAnanthCVSmulianJCScorzaWEKnuppelRAThe impact of prenatal care on postneonatal deaths in the presence and absence of antenatal high-risk conditionsAm J Obstet Gynecol20021871258126212439516
   PubMed Web of Science ®Google Scholar
• KellyRHDanielsenBHGoldingJMAndersTFGilbertWMZatzickDFAdequacy of prenatal care among women with psychiatric diagnoses giving birth in California in 1994 and 1995Psychiatr Serv1999501584159010577877
   PubMed Web of Science ®Google Scholar
• KimDRSockolLESammelMDKellyCMoseleyMEppersonCNElevated risk of adverse obstetric outcomes in pregnant women with depressionArch Womens Ment Health20131647548223934018
   PubMed Web of Science ®Google Scholar
• MulderEJRobles de MedinaPGHuizinkACVan den BerghBRBuitelaarJKVisserGHPrenatal maternal stress: effects on pregnancy and the (unborn) childEarly Hum Dev20027031412441200
   PubMed Web of Science ®Google Scholar
• GroteNKBridgeJAGavinARMelvilleJLIyengarSKatonWJA meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restrictionArch Gen Psychiatry2010671012102420921117
   PubMed Web of Science ®Google Scholar
• SteerRASchollTOHedigerMLFischerRLSelf-reported depression and negative pregnancy outcomesJ Clin Epidemiol199245109310991474405
   PubMed Web of Science ®Google Scholar
• DayanJCreveuilCMarksMNPrenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort study among women with early and regular carePsychosom Med20066893894617079701
   PubMed Web of Science ®Google Scholar
• DiegoMAFieldTHernandez-ReifMSchanbergSKuhnCGonzalez-QuinteroVHPrenatal depression restricts fetal growthEarly Hum Dev200985657018723301
   PubMed Web of Science ®Google Scholar
• RahmanAIqbalZBunnJLovelHHarringtonRImpact of maternal depression on infant nutritional status and illness: a cohort studyArch Gen Psychiatry20046194695215351773
   PubMed Web of Science ®Google Scholar
• UguzFGezgincKYaziciFAre major depression and generalized anxiety disorder associated with intrauterine growth restriction in pregnant women? A case-control studyGen Hosp Psychiatry201133640. e7e921749842
   PubMed Web of Science ®Google Scholar
• PaarlbergKMVingerhoetsAJPasschierJDekkerGAHeinenAGvan GeijnHPPsychosocial predictors of low birthweight: a prospective studyBr J Obstet Gynaecol199910683484110453835
   PubMedGoogle Scholar
• EvansJHeronJPatelRRWilesNDepressive symptoms during pregnancy and low birth weight at termBr J Psychiatry2007191848517602131
   PubMed Web of Science ®Google Scholar
• MarcusSMDepression during pregnancy: rates, risks and consequences – Motherisk Update 2008Can J Clin Pharmacol200916e15e2219164843
   PubMedGoogle Scholar
• GrigoriadisSVonderPortenEHMamisashviliLThe impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysisJ Clin Psychiatry201374e321e34123656857
   PubMed Web of Science ®Google Scholar
• McFarlandJSalisburyALBattleCLHawesKHalloranKLesterBMMajor depressive disorder during pregnancy and emotional attachment to the fetusArch Womens Ment Health20111442543421938509
   PubMed Web of Science ®Google Scholar
• DeaveTHeronJEvansJEmondAThe impact of maternal depression in pregnancy on early child developmentBJOG20081151043105118651886
   PubMed Web of Science ®Google Scholar
• PaulsonJFKeefeHALeifermanJAEarly parental depression and child language developmentJ Child Psychol Psychiatry20095025426219175819
   PubMed Web of Science ®Google Scholar
• NulmanIRovetJStewartDEChild development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled studyAm J Psychiatry20021591889189512411224
   PubMed Web of Science ®Google Scholar
• MisriSReebyePKendrickKInternalizing behaviors in 4-year-old children exposed in utero to psychotropic medicationsAm J Psychiatry20061631026103216741203
   PubMed Web of Science ®Google Scholar
• MurrayLSinclairDCooperPDucournauPTurnerPSteinAThe socioemotional development of 5-year-old children of postnatally depressed mothersJ Child Psychol Psychiatry1999401259127110604404
   PubMed Web of Science ®Google Scholar
• DowneyGCoyneJCChildren of depressed parents: an integrative reviewPsychol Bull199010850762200073
   PubMed Web of Science ®Google Scholar
• PilowskyDJWickramaratnePJRushAJChildren of currently depressed mothers: a STAR*D ancillary studyJ Clin Psychiatry20066712613616426099
   PubMed Web of Science ®Google Scholar
• WeissmanMMPilowskyDJWickramaratnePJRemissions in maternal depression and child psychopathology: a STAR*D-child reportJAMA20062951389139816551710
   PubMed Web of Science ®Google Scholar
• PilowskyDJWickramaratnePTalatiAChildren of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child StudyAm J Psychiatry20081651136114718558646
   PubMed Web of Science ®Google Scholar
• CohenLSAltshulerLLHarlowBLRelapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatmentJAMA200629549950716449615
   PubMed Web of Science ®Google Scholar
• WisnerKLSitDKHanusaBHMajor depression and antidepressant treatment: impact on pregnancy and neonatal outcomesAm J Psychiatry200916655756619289451
   PubMed Web of Science ®Google Scholar
• YonkersKAGotmanNSmithMVDoes antidepressant use attenuate the risk of a major depressive episode in pregnancy?Epidemiology20112284885421900825
   PubMed Web of Science ®Google Scholar
• ClaridgeAMEfficacy of systemically oriented psychotherapies in the treatment of perinatal depression: a meta-analysisArch Womens Ment Health20141731524240636
   PubMed Web of Science ®Google Scholar
• SockolLEEppersonCNBarberJPA meta-analysis of treatments for perinatal depressionClin Psychol Rev20113183984921545782
   PubMed Web of Science ®Google Scholar
• BrandonARCeccottiNHynanLSShivakumarGJohnsonNJarrettRBProof of concept: partner-assisted interpersonal psychotherapy for perinatal depressionArch Womens Ment Health20121546948023053218
   PubMed Web of Science ®Google Scholar
• O’MahenHHimleJAFedockGHenshawEFlynnHA pilot randomized controlled trial of cognitive behavioral therapy for perinatal depression adapted for women with low incomesDepress Anxiety20133067968723319454
   PubMed Web of Science ®Google Scholar
• MeagerIMilgromJGroup treatment for postpartum depression: a pilot studyAust N Z J Psychiatry1996308528609034477
   PubMed Web of Science ®Google Scholar
• ApplebyLWarnerRWhittonAFaragherBA controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depressionBMJ19973149329369099116
   PubMed Web of Science ®Google Scholar
• ChabrolHTeissedreFSaint-JeanMTeisseyreNRogeBMulletEPrevention and treatment of post-partum depression: a controlled randomized study on women at riskPsychol Med2002321039104712214785
   PubMed Web of Science ®Google Scholar
• GlazierRHElgarFJGoelVHolzapfelSStress, social support, and emotional distress in a community sample of pregnant womenJ Psychosom Obstet Gynaecol20042524725515715023
   PubMed Web of Science ®Google Scholar
• St-AndréMPsychotherapy during pregnancy: opportunities and challengesAm J Psychother1993475725908285302
   PubMed Web of Science ®Google Scholar
• NascimentoSLSuritaFGCecattiJGPhysical exercise during pregnancy: a systematic reviewCurr Opin Obstet Gynecol20122438739423014142
   PubMed Web of Science ®Google Scholar
• BlumenthalJABabyakMAMooreKAEffects of exercise training on older patients with major depressionArch Intern Med19991592349235610547175
   PubMed Web of Science ®Google Scholar
• BlumenthalJABabyakMADoraiswamyPMExercise and pharmacotherapy in the treatment of major depressive disorderPsychosom Med20076958759617846259
   PubMed Web of Science ®Google Scholar
• BabyakMBlumenthalJAHermanSExercise treatment for major depression: maintenance of therapeutic benefit at 10 monthsPsychosom Med20006263363811020092
   PubMed Web of Science ®Google Scholar
• Robledo-ColoniaAFSandoval-RestrepoNMosquera-ValderramaYFEscobar-HurtadoCRamírez-VélezRAerobic exercise training during pregnancy reduces depressive symptoms in nulliparous women: a randomised trialJ Physiother20125891522341377
   PubMed Web of Science ®Google Scholar
• GastonAPrapavessisHTired, moody and pregnant? Exercise may be the answerPsychol Health2013281353136923837826
   PubMed Web of Science ®Google Scholar
• SongøygardKMStafneSNEvensenKASalvesenKAVikTMørkvedSDoes exercise during pregnancy prevent postnatal depression? A randomized controlled trialActa Obstet Gynecol Scand201291626721880023
   PubMed Web of Science ®Google Scholar
• GoldenRNGaynesBNEkstromRDThe efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidenceAm J Psychiatry200516265666215800134
   PubMed Web of Science ®Google Scholar
• EvenCSchroderCMFriedmanSRouillonFEfficacy of light therapy in nonseasonal depression: a systematic reviewJ Affect Disord2008108112317950467
   PubMed Web of Science ®Google Scholar
• OrenDAWisnerKLSpinelliMAn open trial of morning light therapy for treatment of antepartum depressionAm J Psychiatry200215966666911925310
   PubMed Web of Science ®Google Scholar
• EppersonCNTermanMTermanJSRandomized clinical trial of bright light therapy for antepartum depression: preliminary findingsJ Clin Psychiatry20046542142515096083
   PubMed Web of Science ®Google Scholar
• Wirz-JusticeABaderAFrischUA randomized, double-blind, placebo-controlled study of light therapy for antepartum depressionJ Clin Psychiatry20117298699321535997
   PubMed Web of Science ®Google Scholar
• KimDREppersonNPareEAn open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorderJ Womens Health (Larchmt)20112025526121314450
   PubMed Web of Science ®Google Scholar
• Hızlı SayarGOztenETufanETranscranial magnetic stimulation during pregnancyArch Womens Ment Health20141731131524248413
   PubMed Web of Science ®Google Scholar
• MillerLJUse of electroconvulsive therapy during pregnancyHosp Community Psychiatry1994454444508045538
   PubMedGoogle Scholar
• O’ReardonJPCristanchoMAvon AndreaeCVCristanchoPWeissDAcute and maintenance electroconvulsive therapy for treatment of severe major depression during the second and third trimesters of pregnancy with infant follow-up to 18 months: case report and review of the literatureJ ECT201127e23e2620562638
   PubMed Web of Science ®Google Scholar
• RabheruKThe use of electroconvulsive therapy in special patient populationsCan J Psychiatry20014671071911692973
   PubMed Web of Science ®Google Scholar
• LeiknesKACookeMJJarosch-von SchwederLHarboeIHoieBElectroconvulsive therapy during pregnancy: a systematic review of case studiesArch Womens Ment Health Epub11242013
   PubMed Web of Science ®Google Scholar
• DennisCLAllenKInterventions (other than pharmacological, psychosocial or psychological) for treating antenatal depressionCochrane Database Syst Rev2008CD00679518843730
   PubMed Web of Science ®Google Scholar
• SadoMOtaEStickleyAMoriRHypnosis during pregnancy, childbirth, and the postnatal period for preventing postnatal depressionCochrane Database Syst Rev20126CD00906222696381
   PubMed Web of Science ®Google Scholar
• ManberRSchnyerRNLyellDAcupuncture for depression during pregnancy: a randomized controlled trialObstet Gynecol201011551152020177281
   PubMed Web of Science ®Google Scholar
• RynnLCragonJCorreaAUpdate of overall prevalence of major birth defects – Atlanta, Georgia, 1978–2005MMWR Morb Mortal Wkly Rep2008571518185492
   PubMedGoogle Scholar
• FinnellRHTeratology: general considerations and principlesJ Allergy Clin Immunol1999103S337S3429949334
   PubMed Web of Science ®Google Scholar
• MalmHPrenatal exposure to selective serotonin reuptake inhibitors and infant outcomeTher Drug Monit20123460761423042258
   PubMed Web of Science ®Google Scholar
• ChambersCDJohnsonKADickLMFelixRJJonesKLBirth outcomes in pregnant women taking fluoxetineN Engl J Med1996335101010158793924
   PubMed Web of Science ®Google Scholar
• EricsonAKällénBWiholmBDelivery outcome after the use of antidepressants in early pregnancyEur J Clin Pharmacol19995550350810501819
   PubMed Web of Science ®Google Scholar
• GoldsteinDJCorbinLASundellKLEffects of first-trimester fluoxetine exposure on the newbornObstet Gynecol1997897137189166307
   PubMed Web of Science ®Google Scholar
• KulinNAPastuszakASageSRPregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter studyJAMA19982796096109486756
   PubMed Web of Science ®Google Scholar
• PastuszakASchick-BoschettoBZuberCPregnancy outcome following first-trimester exposure to fluoxetine (Prozac)JAMA1993269224622488474204
   PubMed Web of Science ®Google Scholar
• BoboWVEpsteinRAJrHayesRMThe effect of regulatory advisories on maternal antidepressant prescribing, 1995–2007: an interrupted time series study of 228,876 pregnanciesArch Womens Ment Health201417172624196827
   PubMed Web of Science ®Google Scholar
• NordengHvan GelderMMSpigsetOKorenGEinarsonAEberhard-GranMPregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort StudyJ Clin Psychopharmacol20123218619422367660
   PubMed Web of Science ®Google Scholar
• MalmHArtamaMGisslerMRitvanenASelective serotonin reuptake inhibitors and risk for major congenital anomaliesObstet Gynecol201111811112021646927
   PubMed Web of Science ®Google Scholar
• ReisMKällénBDelivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish dataPsychol Med2010401723173320047705
   PubMed Web of Science ®Google Scholar
• EinarsonAChoiJEinarsonTRKorenGIncidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort studyCan J Psychiatry20095424224619321030
   PubMed Web of Science ®Google Scholar
• WichmanCLMooreKMLangTRSt SauverJLHeiseRHJrWatsonWJCongenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancyMayo Clin Proc200984232719121250
   PubMed Web of Science ®Google Scholar
• DavisRLRubanowiceDMcPhillipsHRisks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancyPharmacoepidemiol Drug Saf2007161086109417729378
   PubMed Web of Science ®Google Scholar
• KällénBAOtterbladOPMaternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformationsBirth Defects Res A Clin Mol Teratol20077930130817216624
   PubMed Web of Science ®Google Scholar
• LouikCLinAEWerlerMMHernández-DíazSMitchellAAFirst-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defectsN Engl J Med20073562675268317596601
   PubMed Web of Science ®Google Scholar
• MalmHKlaukkaTNeuvonenPJRisks associated with selective serotonin reuptake inhibitors in pregnancyObstet Gynecol20051061289129616319254
   PubMed Web of Science ®Google Scholar
• ChambersCDHernandez-DiazSVan MarterLJSelective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newbornN Engl J Med200635457958716467545
   PubMed Web of Science ®Google Scholar
• HendrickVSmithLMSuriRHwangSHaynesDAltshulerLBirth outcomes after prenatal exposure to antidepressant medicationAm J Obstet Gynecol200318881281512634662
   PubMed Web of Science ®Google Scholar
• Klieger-GrossmannCWeitznerBPanchaudAPregnancy outcomes following use of escitalopram: a prospective comparative cohort studyJ Clin Pharmacol20125276677022075232
   PubMed Web of Science ®Google Scholar
• ManakovaEHubickovaLAntidepressant drug exposure during pregnancy. CZTIS small prospective studyNeuro Endocrinol Lett201132Suppl 1535622167208
   PubMed Web of Science ®Google Scholar
• MylesNNewallHWardHLargeMSystematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformationsAust N Z J Psychiatry2013471002101223761574
   PubMed Web of Science ®Google Scholar
• Bar-OzBEinarsonTEinarsonAParoxetine and congenital malformations: meta-analysis and consideration of potential confounding factorsClin Ther20072991892617697910
   PubMed Web of Science ®Google Scholar
• GrigoriadisSVonderPortenEHMamisashviliLAntidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidenceJ Clin Psychiatry201374e293e30823656855
   PubMed Web of Science ®Google Scholar
• RigginLFrankelZMorettiMPupcoAKorenGThe fetal safety of fluoxetine: a systematic review and meta-analysisJ Obstet Gynaecol Can20133536236923660045
   PubMedGoogle Scholar
• RahimiRNikfarSAbdollahiMPregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trialsReprod Toxicol20062257157516720091
   PubMed Web of Science ®Google Scholar
• AddisAKorenGSafety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studiesPsychol Med200030899410722179
   PubMed Web of Science ®Google Scholar
• BakkerMKKerstjens-FrederikseWSBuysCHde WalleHEde Jong-van den BergLTFirst-trimester use of paroxetine and congenital heart defects: a population-based case-control studyBirth Defects Res A Clin Mol Teratol2010889410019937603
   PubMed Web of Science ®Google Scholar
• BérardARamosEReyEBlaisLSt-AndréMOraichiDFirst trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosageBirth Defects Res B Dev Reprod Toxicol200780182717187388
   PubMed Web of Science ®Google Scholar
• MerlobPBirkESirotaLAre selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmurBirth Defects Res A Clin Mol Teratol20098583784119691085
   PubMed Web of Science ®Google Scholar
• PedersenLHHenriksenTBVestergaardMOlsenJBechBHSelective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort studyBMJ2009339b356919776103
   PubMed Web of Science ®Google Scholar
• OberlanderTFWarburtonWMisriSRiggsWAghajanianJHertzmanCMajor congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health dataBirth Defects Res B Dev Reprod Toxicol200883687618293409
   PubMed Web of Science ®Google Scholar
• Jimenez-SolemEAndersenJTPetersenMExposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort studyBMJ Open20122e001148
   PubMed Web of Science ®Google Scholar
• KällénBOtterbladOPAntidepressant drugs during pregnancy and infant congenital heart defectReprod Toxicol20062122122216406480
   PubMed Web of Science ®Google Scholar
• EinarsonAPistelliADeSantisMEvaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancyAm J Psychiatry200816574975218381907
   PubMed Web of Science ®Google Scholar
• ReisMKällénBCombined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register studyBMJ Open20133e002166
   Web of Science ®Google Scholar
• Diav-CitrinOShechtmanSWeinbaumDParoxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational studyBr J Clin Pharmacol20086669570518754846
   PubMed Web of Science ®Google Scholar
• ColeJAModellJGHaightBRCosmatosISStolerJMWalkerAMBupropion in pregnancy and the prevalence of congenital malformationsPharmacoepidemiol Drug Saf20071647448416897811
   PubMed Web of Science ®Google Scholar
• RamosESt-AndréMReyEOraichiDBerardADuration of antidepressant use during pregnancy and risk of major congenital malformationsBr J Psychiatry200819234435018450657
   PubMed Web of Science ®Google Scholar
• NulmanIKorenGThe safety of fluoxetine during pregnancy and lactationTeratology1996533043088879088
   PubMedGoogle Scholar
• WogeliusPNørgaardMGislumMMaternal use of selective serotonin reuptake inhibitors and risk of congenital malformationsEpidemiology20061770170417028507
   PubMed Web of Science ®Google Scholar
• KällénBAOlaussonPOMaternal drug use in early pregnancy and infant cardiovascular defectReprod Toxicol20031725526112759093
   PubMed Web of Science ®Google Scholar
• UdechukuANguyenTHillRSzegoKAntidepressants in pregnancy: a systematic reviewAust N Z J Psychiatry20104497899621034181
   PubMed Web of Science ®Google Scholar
• DjulusJKorenGEinarsonTRExposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomesJ Clin Psychiatry2006671280128416965209
   PubMed Web of Science ®Google Scholar
• LennestalRKällénBDelivery outcome in relation to maternal use of some recently introduced antidepressantsJ Clin Psychopharmacol20072760761318004128
   PubMed Web of Science ®Google Scholar
• SackettJCWellerRAWellerEBSelective serotonin reuptake inhibitor use during pregnancy and possible neonatal complicationsCurr Psychiatry Rep20091125325719470288
   PubMed Web of Science ®Google Scholar
• AdamsMHudginsLThe importance of minor anomalies in the evaluation of the newbornNeoreviews20034e99e104
   Google Scholar
• Walsh-SukysMCTysonJEWrightLLPersistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomesPediatrics2000105142010617698
   PubMed Web of Science ®Google Scholar
• Hernández-DíazSVan MarterLJWerlerMMLouikCMitchellAARisk factors for persistent pulmonary hypertension of the newbornPediatrics2007120e272e28217671038
   PubMed Web of Science ®Google Scholar
• KällénBOlaussonPOMaternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newbornPharmacoepidemiol Drug Saf20081780180618314924
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationPublic health advisory: treatment challenges of depression in pregnancy and the possibility of persistent pulmonary hypertension in newborns2013 Available from: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/drugsafetyinformationforheathcareprofessionals/publichealthadvisories/ucm124348.htmAccessed August 6, 2014
   Google Scholar
• AndradeSEMcPhillipsHLorenDAntidepressant medication use and risk of persistent pulmonary hypertension of the newbornPharmacoepidemiol Drug Saf20091824625219148882
   PubMed Web of Science ®Google Scholar
• WilsonKLZeligCMHarveyJPCunninghamBSDolinskyBMNapolitanoPGPersistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitorsAm J Perinatol201128192420607643
   PubMed Web of Science ®Google Scholar
• KielerHArtamaMEngelandASelective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countriesBMJ2012344d801222240235
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA drug safety communication: selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies2011 Available from: http://www.fda.gov/drugs/drugsafety/ucm283375.htmAccessed August 6, 2014
   Google Scholar
• KalraSEinarsonAKorenGTaking antidepressants during late pregnancy. How should we advise women?Can Fam Physician2005511077107816121827
   PubMed Web of Science ®Google Scholar
• Moses-KolkoELBogenDPerelJNeonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applicationsJAMA20052932372238315900008
   PubMed Web of Science ®Google Scholar
• IsbisterGKDawsonAWhyteIMPriorFHClancyCSmithAJNeonatal paroxetine withdrawal syndrome or actually serotonin syndrome?Arch Dis Child Fetal Neonatal Ed200185F147F14811561552
   PubMed Web of Science ®Google Scholar
• OberlanderTFMisriSFitzgeraldCEKostarasXRurakDRiggsWPharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposureJ Clin Psychiatry20046523023715003078
   PubMed Web of Science ®Google Scholar
• WayCMSafety of newer antidepressants in pregnancyPharmacotherapy20072754655217381382
   PubMed Web of Science ®Google Scholar
• MisriSSivertzKTricyclic drugs in pregnancy and lactation: a preliminary reportInt J Psychiatry Med1991211571711894455
   PubMed Web of Science ®Google Scholar
• SchimmellMSKatzEZShaagYPastuszakAKorenGToxic neonatal effects following maternal clomipramine therapyJ Toxicol Clin Toxicol1991294794841749054
   PubMed Web of Science ®Google Scholar
• CoweLLloydDJDawlingSNeonatal convulsions caused by withdrawal from maternal clomipramineBr Med J (Clin Res Ed)198228418371838
   PubMed Web of Science ®Google Scholar
• FerreiraECarcellerAMAgogueCEffects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonatesPediatrics2007119525917200271
   PubMed Web of Science ®Google Scholar
• Ter HorstPGJansmanFGvan LingenRASmitJPde Jong-van den BergLTBrouwersJRPharmacological aspects of neonatal antidepressant withdrawalObstet Gynecol Surv20086326727918348740
   PubMed Web of Science ®Google Scholar
• BoucherNKorenGBeaulac-BaillargeonLMaternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrationsTher Drug Monit20093140440919455083
   PubMed Web of Science ®Google Scholar
• LattimoreKADonnSMKacirotiNKemperARNealCRJrVazquezDMSelective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysisJ Perinatol20052559560416015372
   PubMedGoogle Scholar
• KällénBNeonate characteristics after maternal use of antidepressants in late pregnancyArch Pediatr Adolesc Med200415831231615066868
   PubMed Web of Science ®Google Scholar
• GrigoriadisSVonderPortenEHMamisashviliLThe effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysisJ Clin Psychiatry201374e309e32023656856
   PubMed Web of Science ®Google Scholar
• CasperRCFleisherBELee-AncajasJCFollow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancyJ Pediatr200314240240812712058
   PubMed Web of Science ®Google Scholar
• MaschiSClavennaACampiRSchiavettiBBernatMBonatiMNeonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort studyBJOG200811528328917903222
   PubMed Web of Science ®Google Scholar
• GrigoriadisSMamisashviliLRossLEAchieving the balance: treating depressed pregnant women with antidepressantsJ Clin Psychiatry20137437537623656844
   PubMed Web of Science ®Google Scholar
• KorenGNordengHAntidepressant use during pregnancy: the benefit-risk ratioAm J Obstet Gynecol201220715716322425404
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA MedWatch drug alert on Effexor and SSRIs2004 Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154975.htmAccessed August 6, 2014
   Google Scholar
• WarburtonWHertzmanCOberlanderTFA register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal healthActa Psychiatr Scand201012147147919878137
   PubMed Web of Science ®Google Scholar
• EngleWAMorbidity and mortality in late preterm and early term newborns: a continuumClin Perinatol20113849351621890021
   PubMed Web of Science ®Google Scholar
• Shapiro-MendozaCKLackritzEMEpidemiology of late and moderate preterm birthSemin Fetal Neonatal Med20121712012522264582
   PubMed Web of Science ®Google Scholar
• RossLEGrigoriadisSMamisashviliLSelected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysisJAMA Psychiatry20137043644323446732
   PubMed Web of Science ®Google Scholar
• SimonGECunninghamMLDavisRLOutcomes of prenatal antidepressant exposureAm J Psychiatry20021592055206112450956
   PubMed Web of Science ®Google Scholar
• LundNPedersenLHenriksenTSSRI exposure in utero and pregnancy outcomeJ Matern Fetal Neonatal Med20061945
   Web of Science ®Google Scholar
• WenSWYangQGarnerPSelective serotonin reuptake inhibitors and adverse pregnancy outcomesAm J Obstet Gynecol200619496196616580283
   PubMed Web of Science ®Google Scholar
• LewisAJGalballyMOpieGBuistANeonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medicationAust N Z J Psychiatry20104448248720397792
   PubMed Web of Science ®Google Scholar
• PearsonKHNonacsRMVigueraACBirth outcomes following prenatal exposure to antidepressantsJ Clin Psychiatry2007681284128917854255
   PubMed Web of Science ®Google Scholar
• EinarsonAChoiJEinarsonTRKorenGAdverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birthDepress Anxiety201027353819691030
   PubMed Web of Science ®Google Scholar
• PalmstenKHernández-DíazSCan nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs?Epidemiology20122368668822872113
   PubMed Web of Science ®Google Scholar
• DavalosDBYadonCATregellasHCUntreated prenatal maternal depression and the potential risks to offspring: a reviewArch Womens Ment Health20121511422215285
   PubMed Web of Science ®Google Scholar
• SuriRAltshulerLHellemannGBurtVKAquinoAMintzJEffects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birthAm J Psychiatry20071641206121317671283
   PubMed Web of Science ®Google Scholar
• YonkersKANorwitzERSmithMVDepression and serotonin reuptake inhibitor treatment as risk factors for preterm birthEpidemiology20122367768522627901
   PubMed Web of Science ®Google Scholar
• García-EnguídanosACalleMEValeroJLunaSDomínguez-RojasVRisk factors in miscarriage: a reviewEur J Obstet Gynecol Reprod Biol200210211111911950476
   PubMed Web of Science ®Google Scholar
• GoddijnMLeschotNJGenetic aspects of miscarriageBaillieres Best Pract Res Clin Obstet Gynaecol20001485586511023805
   PubMed Web of Science ®Google Scholar
• HemelsMEEinarsonAKorenGLanctotKLEinarsonTRAntidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysisAnn Pharmacother20053980380915784808
   PubMed Web of Science ®Google Scholar
• EinarsonAFatoyeBSarkarMPregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled studyAm J Psychiatry20011581728173011579012
   PubMed Web of Science ®Google Scholar
• Chun-Fai-ChanBKorenGFayezIPregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative studyAm J Obstet Gynecol200519293293615746694
   PubMed Web of Science ®Google Scholar
• EinarsonAChoiJEinarsonTRKorenGRates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective databaseJ Obstet Gynaecol Can20093145245619604427
   PubMedGoogle Scholar
• Nakhai-PourHRBroyPBérardAUse of antidepressants during pregnancy and the risk of spontaneous abortionCMAJ20101821031103720513781
   PubMed Web of Science ®Google Scholar
• EinarsonABonariLVoyer-LavigneSA multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancyCan J Psychiatry20034810611012655908
   PubMed Web of Science ®Google Scholar
• McElhattonPRGarbisHMElefantEThe outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS)Reprod Toxicol1996102852948829251
   PubMed Web of Science ®Google Scholar
• TuccoriMTestiAAntonioliLSafety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a reviewClin Ther200931Pt 11426145319698902
   PubMed Web of Science ®Google Scholar
• KjaersgaardMIParnerETVestergaardMPrenatal antidepressant exposure and risk of spontaneous abortion – a population-based studyPLoS One20138e7209524015208
   PubMed Web of Science ®Google Scholar
• WalfischASermerCMatokIEinarsonAKorenGPerception of teratogenic risk and the rated likelihood of pregnancy termination: association with maternal depressionCan J Psychiatry20115676176722152645
   PubMed Web of Science ®Google Scholar
• BonariLPintoNAhnEEinarsonASteinerMKorenGPerinatal risks of untreated depression during pregnancyCan J Psychiatry20044972673515633850
   PubMed Web of Science ®Google Scholar
• OberlanderTFWarburtonWMisriSAghajanianJHertzmanCEffects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based studyBr J Psychiatry200819233834318450656
   PubMed Web of Science ®Google Scholar
• HeikkinenTEkbladUKeroPEkbladSLaineKCitalopram in pregnancy and lactationClin Pharmacol Ther20027218419112189365
   PubMed Web of Science ®Google Scholar
• SivojelezovaAShuhaiberSSarkissianLEinarsonAKorenGCitalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcomeAm J Obstet Gynecol20051932004200916325604
   PubMed Web of Science ®Google Scholar
• CosteiAMKozerEHoTItoSKorenGPerinatal outcome following third trimester exposure to paroxetineArch Pediatr Adolesc Med20021561129113212413342
   PubMed Web of Science ®Google Scholar
• NulmanIRovetJStewartDENeurodevelopment of children exposed in utero to antidepressant drugsN Engl J Med19973362582628995088
   PubMed Web of Science ®Google Scholar
• CohenLSHellerVLBaileyJWGrushLAblonJSBouffardSMBirth outcomes following prenatal exposure to fluoxetineBiol Psychiatry200048996100011082474
   PubMed Web of Science ®Google Scholar
• SuriRAltshulerLHendrickVRasgonNLeeEMintzJThe impact of depression and fluoxetine treatment on obstetrical outcomeArch Womens Ment Health2004719320015241665
   PubMedGoogle Scholar
• LaineKHeikkinenTEkbladUKeroPEffects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrationsArch Gen Psychiatry20036072072612860776
   PubMed Web of Science ®Google Scholar
• WeinbergerAHMazureCMMorlettAMcKeeSATwo decades of smoking cessation treatment research on smokers with depression: 1990–2010Nicotine Tob Res2013151014103123100459
   PubMed Web of Science ®Google Scholar
• DavidsonKMRitsonEBThe relationship between alcohol dependence and depressionAlcohol Alcohol1993281471558517885
   PubMed Web of Science ®Google Scholar
• BodnarLMWisnerKLMoses-KolkoESitDKHanusaBHPrepregnancy body mass index, gestational weight gain, and the likelihood of major depressive disorder during pregnancyJ Clin Psychiatry2009701290129619607761
   PubMed Web of Science ®Google Scholar
• WisnerKLBogenDLSitDDoes fetal exposure to SSRIs or maternal depression impact infant growth?Am J Psychiatry201317048549323511234
   PubMed Web of Science ®Google Scholar
• BeckATSteerRABrownGKBeck Depression Inventory2nd edSan AntonioPsychological Corporation1996
   Google Scholar
• SibaiBHDiagnosis and management of gestational hypertension and preeclampsiaObstet Gynecol200310218119212850627
   PubMed Web of Science ®Google Scholar
• PodymowTAugustPHypertension in pregnancyAdv Chronic Kidney Dis20071417819017395120
   PubMed Web of Science ®Google Scholar
• GroftonENCapewellVNataleRGrattonRJObstetrical intervention rates and maternal and neonatal outcomes of women with gestational hypertensionAm J Obstet Gynecol200118579880311641654
   PubMed Web of Science ®Google Scholar
• SteegersEAvon DadelszenPDuvekotJJPijneborgRPre-eclampsiaLancet201037663164420598363
   PubMed Web of Science ®Google Scholar
• QiuCWilliamsMACalderon-MargalitRCripeSMSorensenTKPreeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancyAm J Hypertens20092239740219197246
   PubMed Web of Science ®Google Scholar
• KurkiTHiilesmaaVRaitasaloRMattilaHYlikorkalaODepression and anxiety in early pregnancy and risk for preeclampsiaObstet Gynecol20009548749010725477
   PubMed Web of Science ®Google Scholar
• QiuCSanchezSELamNGarciaPWilliamsMAAssociations of depression and depressive symptoms with preeclampsia: results from a Peruvian case-control studyBMC Womens Health200771517900360
   PubMedGoogle Scholar
• TohSMitchellAALouikCWerlerMMChambersCDHernández-DíazSSelective serotonin reuptake inhibitor use and risk of gestational hypertensionAm J Psychiatry200916632032819122006
   PubMed Web of Science ®Google Scholar
• De VeraMABérardAAntidepressant use during pregnancy and the risk of pregnancy-induced hypertensionBr J Clin Pharmacol20127436236922435711
   PubMed Web of Science ®Google Scholar
• PalmstenKSetoguchiSMargulisAVPatrickARHernández-DíazSElevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?Am J Epidemiol201217598899722442287
   PubMed Web of Science ®Google Scholar
• ThaseMEffects of venlafaxine on blood pressure: a meta-analysis of original data from 3,744 depressed patientsJ Clin Psychiatry1998595025099818630
   PubMed Web of Science ®Google Scholar
• WalshBTHadiganCMWongLMIncreased pulse and blood pressure associated with desipramine treatment of bulimia nervosaJ Clin Psychopharmacol19921231631681629381
   PubMed Web of Science ®Google Scholar
• GoldbergJFErnstCLHypertensionGoldergJFErnstCLManaging the Side Effects of Psychotropic MedicationsWashingtonAmerican Psychiatric2012137138
   Google Scholar
• ReebyePNMorisonSJPanikkarHMisriSGrunauREAffect expression in prenatally psychotropic exposed and nonexposed mother-infant dyadsInfant Ment Health J200223403416
   Web of Science ®Google Scholar
• OberlanderTFReebyePMisriSPapsdorfMKimJGrunauREExternalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancyArch Pediatr Adolesc Med2007161222917199063
   PubMed Web of Science ®Google Scholar
• PedersenLHHenriksenTBOlsenJFetal exposure to antidepressants and normal milestone development at 6 and 19 months of agePediatrics2010125e600e60820176667
   PubMed Web of Science ®Google Scholar
• SieSDWenninkJMvan DrielJJMaternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactationArch Dis Child Fetal Neonatal Ed201297F472F47623080479
   PubMed Web of Science ®Google Scholar
• Vesga-LópezOBlancoCKeyesKOlfsonMGrantBFHasinDSPsychiatric disorders in pregnant and postpartum women in the United StatesArch Gen Psychiatry20086580581518606953
   PubMed Web of Science ®Google Scholar
• WickramaratnePGameroffMJPilowskyDJChildren of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child studyAm J Psychiatry201116859360221406462
   PubMed Web of Science ®Google Scholar
• FosterCEWebsterMCWeissmanMMRemission of maternal depression: relations to family functioning and youth internalizing and externalizing symptomsJ Clin Child Adolesc Psychol20083771472418991123
   PubMed Web of Science ®Google Scholar
• CoiroMJRIleyABroitmanMMirandaJEffects on children of treating their mothers’ depression: results of a 12-month follow-upPsychiatr Serv20126335736322388476
   PubMed Web of Science ®Google Scholar
• GunlicksMLWeissmanMMChange in child psychopathology with improvement in parental depression: a systematic reviewJ Am Acad Child Adolesc Psychiatry20084737938918388766
   PubMed Web of Science ®Google Scholar
• WisnerKLZarinDAHolmboeESRisk-benefit decision making for treatment of depression during pregnancyAm J Psychiatry20001571933194011097953
   PubMed Web of Science ®Google Scholar
• ChaudronLHComplex challenges in treating depression during pregnancyAm J Psychiatry2013170122023288385
   PubMed Web of Science ®Google Scholar